PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK.
Mohid S KhanKathryn CookMartin O WeickertLouise DaviesDavid Mark PritchardMelissa DayTahir ShahDiana HullMartyn E CaplinMelissa BackChristelle PommieKate HiggsPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)
Almost all patients preferred to receive LAN treatment at home rather than in hospital with increased convenience and psychological benefits reported as key reasons for this preference.